HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $40 Price Target

Benzinga · 10/18 11:03
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $40 price target.